From the Institute of Cardiovascular Research, Royal Holloway University of London, Egham, United Kingdom (T.S.H., S.S., P.S.).
School of Physiology, Pharmacology and Neuroscience, University of Bristol, United Kingdom (C.H.F.).
Stroke. 2020 Feb;51(2):594-600. doi: 10.1161/STROKEAHA.119.027740. Epub 2019 Dec 17.
Background and Purpose- Information on what effect disability before stroke can have on stroke outcome is lacking. We assessed prestroke disability in relation to poststroke hospital outcome. Methods- Analysis of prospectively collected data from the Sentinel Stroke National Audit Programme. A total of 1656 men (mean age ±SD =73.1±13.2 years) and 1653 women (79.3±13.0 years) were admitted to hyperacute stroke units with acute stroke in 4 major UK between 2014 and 2016. Prestroke disability, assessed by modified Rankin Scale (mRS), was tested against poststroke adverse outcomes, adjusted for age, sex, and coexisting morbidities. Results- Compared with patients with prestroke mRS score =0, individuals with prestroke mRS scores =3, 4, or 5 had greater adjusted risks of moderately severe or severe stroke on arrival (4.4% versus 16.7%; odds ratio [OR], 3.2 [95% CI, 2.3-4.6] <0.001); urinary tract infection or pneumonia within 7 days of admission (9.6% versus 35.9%; OR, 3.7 [95% CI, 2.8-4.8] <0.001); mortality (7.2% versus 37.1%; OR, 4.9 [95% CI, 3.7-6.5] <0.001); requiring help with activities of daily living on discharge (12.3% versus 26.7%; OR, 3.1 [95% CI, 2.3-4.1] <0.001); and transferred to new care home (2.4% versus 9.4%; OR, 2.1 [95% CI, 1.3-3.3] =0.002). Patients with mRS scores =1 or 2 had intermediate risk of adverse outcomes. Overall, those with a mRS score =1 or 2 had length of stay on hyperacute stroke units extended by 5.3 days (95% CI, 2.8-7.7; <0.001) and mRS score =3, 4 or 5 by 7.2 days (95% CI, 4.0-10.5; <0.001). Conclusions- Individuals with evidence of prestroke disability, assessed by mRS, had significantly increased risk of poststroke adverse outcomes and longer length of stay on hyperacute stroke units and higher level of care on discharge.
背景与目的-关于卒中前残疾对卒中结局影响的信息尚缺乏。我们评估了卒中前残疾与卒中后住院结局的关系。方法-对 2014 年至 2016 年间英国 4 个主要地区卒中监护病房中急性卒中的 1656 名男性(平均年龄±标准差=73.1±13.2 岁)和 1653 名女性(79.3±13.0 岁)前瞻性收集的数据进行分析。使用改良 Rankin 量表(mRS)评估卒中前残疾,并根据年龄、性别和并存的合并症对不良预后进行调整。结果-与卒中前 mRS 评分为 0 的患者相比,mRS 评分为 3、4 或 5 的患者入院时中度或重度卒中的调整后风险更高(4.4% vs 16.7%;优势比[OR],3.2[95%CI,2.3-4.6],<0.001);入院后 7 天内发生尿路感染或肺炎(9.6% vs 35.9%;OR,3.7[95%CI,2.8-4.8],<0.001);死亡率(7.2% vs 37.1%;OR,4.9[95%CI,3.7-6.5],<0.001);出院时需要日常生活活动帮助(12.3% vs 26.7%;OR,3.1[95%CI,2.3-4.1],<0.001);转往新的护理院(2.4% vs 9.4%;OR,2.1[95%CI,1.3-3.3],=0.002)。mRS 评分为 1 或 2 的患者有中等风险的不良结局。总的来说,mRS 评分为 1 或 2 的患者在卒中监护病房的住院时间延长了 5.3 天(95%CI,2.8-7.7;<0.001),mRS 评分为 3、4 或 5 的患者延长了 7.2 天(95%CI,4.0-10.5;<0.001)。结论-使用 mRS 评估卒中前残疾的患者发生卒中后不良结局的风险显著增加,并且在卒中监护病房的住院时间延长,出院时的护理水平更高。